141 related articles for article (PubMed ID: 20062011)
1. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
Little L; Stewart CJ
Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium.
Stewart CJ; Little L
Pathology; 2010 Apr; 42(3):217-23. PubMed ID: 20350213
[TBL] [Abstract][Full Text] [Related]
3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions.
El-Ghobashy AA; Shaaban AM; Innes J; Prime W; Herrington CS
Eur J Cancer; 2007 Sep; 43(13):2011-8. PubMed ID: 17693084
[TBL] [Abstract][Full Text] [Related]
5. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
7. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
8. The expression of epithelial specific antigen in cervical intraepithelial neoplasia and adenocarcinoma.
Markaki S; Lazaris D; Papaspirou I; Paulou V
Eur J Gynaecol Oncol; 2004; 25(1):101-3. PubMed ID: 15053074
[TBL] [Abstract][Full Text] [Related]
9. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions.
McCluggage G; McBride H; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528
[TBL] [Abstract][Full Text] [Related]
11. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition.
Koay MH; Crook M; Stewart CJ
Histopathology; 2012 Dec; 61(6):1125-33. PubMed ID: 23190089
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma.
Ali-Fehmi R; Qureshi F; Lawrence WD; Jacques SM
Int J Gynecol Pathol; 2004 Jan; 23(1):1-6. PubMed ID: 14668542
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix.
El-Ghobashy AA; Shaaban AM; Herod J; Innes J; Prime W; Herrington CS
Gynecol Oncol; 2004 Feb; 92(2):628-34. PubMed ID: 14766257
[TBL] [Abstract][Full Text] [Related]
15. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
16. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
17. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
18. New developments in endocervical glandular lesions.
McCluggage WG
Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447
[TBL] [Abstract][Full Text] [Related]
19. Robust expression of EZH2 in endocervical neoplastic lesions.
Makk E; Bálint L; Cifra J; Tornóczky T; Oszter A; Tóth A; Kálmán E; Kovács K
Virchows Arch; 2019 Jul; 475(1):95-104. PubMed ID: 30903272
[TBL] [Abstract][Full Text] [Related]
20. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
